BIOMAT Database Logo BIOMAT Database Logo

Osmotic demyelination syndrome: plasmapheresis versus intravenous immunoglobulin? 2017

Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Department of Neurology, Jackson Memorial Hospital, University of Miami School of Medicine, Miami, FL, USA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011149 Pons The front part of the hindbrain (RHOMBENCEPHALON) that lies between the MEDULLA and the midbrain (MESENCEPHALON) ventral to the cerebellum. It is composed of two parts, the dorsal and the ventral. The pons serves as a relay station for neural pathways between the CEREBELLUM to the CEREBRUM. Pons Varolii,Ponte,Pons Varolius,Pontes,Varolii, Pons,Varolius, Pons
D003711 Demyelinating Diseases Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. Clinically Isolated CNS Demyelinating Syndrome,Clinically Isolated Syndrome, CNS Demyelinating,Demyelinating Disorders,Demyelination,Demyelinating Disease,Demyelinating Disorder,Demyelinations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I
D065626 Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. Fatty Liver, Nonalcoholic,NAFLD,Nonalcoholic Fatty Liver Disease,Nonalcoholic Steatohepatitis,Fatty Livers, Nonalcoholic,Liver, Nonalcoholic Fatty,Livers, Nonalcoholic Fatty,Non alcoholic Fatty Liver Disease,Nonalcoholic Fatty Liver,Nonalcoholic Fatty Livers,Nonalcoholic Steatohepatitides,Steatohepatitides, Nonalcoholic,Steatohepatitis, Nonalcoholic

Related Publications

Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Osmotic demyelination syndrome: variable clinical and radiologic response to intravenous immunoglobulin therapy.
April 2013, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Delayed Presentation of Osmotic Demyelination Syndrome Treated With Plasmapheresis.
October 2023, Cureus,
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction.
August 2019, The Medical journal of Malaysia,
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Osmotic demyelination syndrome.
July 2014, BMJ case reports,
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Osmotic demyelination syndrome.
October 2014, WMJ : official publication of the State Medical Society of Wisconsin,
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Osmotic demyelination syndrome.
June 2010, The American journal of the medical sciences,
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Osmotic demyelination syndrome.
October 2005, BMJ (Clinical research ed.),
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Response to IV immunoglobulin in a case of osmotic demyelination syndrome.
November 2015, BMJ case reports,
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Case Series of Osmotic Demyelination Syndrome Treated With Plasmapheresis: Experience From Two Tertiary Hospitals.
January 2022, Journal of clinical neurology (Seoul, Korea),
Kunakorn Atchaneeyasakul, and Anita Tipirneni, and Salomon Gloria, and Andrew C Berry, and Kush Shah, and Dileep R Yavagal
Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barré Syndrome Management: A Systematic Review.
March 2024, Cureus,
Copied contents to your clipboard!